Stocksigma LogoStocksigma Logo

Titan Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 7,646 (+40.7% YoY | +29.2% QoQ) ■ EBITDA: 1,501 (+60.9% YoY | +20.2% QoQ) ■ EBITDA Margin (%): 19.6 (+247 bps YoY | -147 bps QoQ) ■ PAT: 1,255

Titan Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Titan Biotech Ltd · Financial Result · 05 Nov 2026, 9:09 pm

Titan Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 7,646 (+40.7% YoY | +29.2% QoQ) ■ EBITDA: 1,501 (+60.9% YoY | +20.2% QoQ) ■ EBITDA Margin (%): 19.6 (+247 bps YoY | -147 bps QoQ) ■ PAT: 1,255 (+61.6% YoY | +15.6% QoQ) ■ EPS (INR): 3.04 (-67.7% YoY | +15.6% QoQ)

Original exchange filing (PDF)

More announcements from Titan Biotech Ltd

All Titan Biotech Ltd announcements